about
Seminal Levels of Pro-inflammatory (CXCL1, CXCL9, CXCL10) and Homeostatic (CXCL12) Chemokines in Men With Asymptomatic Chlamydia trachomatis Infection.Levels of Transforming Growth Factor-Beta After Immunization of Mice With in vivo prepared Toxoplasma gondii Excretory/Secretory Proteins.Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and HypertensionThe biological functions, structure and sources of CXCL10 and its outstanding part in the pathophysiology of multiple sclerosis.The Cytotoxic T Lymphocyte Antigen-4 +49A/G Single Nucleotide Polymorphism Association With Visceral Leishmaniasis.Evaluation of NLRC4, NLRP1, and NLRP3, as Components of Inflammasomes, in Chronic Hepatitis B Virus-Infected Patients.Intensity of HLA-A2 Expression Significantly Decreased in Occult Hepatitis B Infection.Decreased expression of toll like receptor signaling molecules in chronic HBV infected patients.Is CCR5-Delta32 mutation associated with diabetic nephropathy in type 2 diabetes?No detected hepatitis B virus-DNA in thalassemic patients infected by hepatitis C virus in Kerman province of Iran.The adapter proteins of TLRs, TRIF and MYD88, are upregulated in depressed individuals.Inhibition of transient receptor potential vanilloid-1 confers neuroprotection, reduces tumor necrosis factor-alpha, and increases IL-10 in a rat stroke model.The Possible Role of Toll-Like Receptor 4 in the Pathology of Stroke.Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients.Defective NF-kB Transcription Factor as the Mediator of Inflammatory Responses: A Study on Depressed Iranian Medical StudentsDownregulation of IL-22 can be considered as a risk factor for onset of type 2 diabetesThe effect of IFN-β 1a on expression of MDA5 and RIG-1 in Multiple Sclerosis patientsUp-regulation of RIP1 and IPS-1 in chronic HBV infected patients
P50
Q35105027-DE8777B6-72AD-46DE-BDDE-6BBE95FBA1EFQ35690920-21B850C6-B0B8-4E9A-9977-D4A4926DCD0CQ36235476-46E8AA28-47E2-480E-BF03-7FCBECA2A0A1Q38197035-5ABA9E3B-46E5-469B-BEC6-574CB6DB9160Q39041628-467D2681-B5EA-44BD-98AE-E2973930FC64Q39281346-FE13CA7E-BEFB-4F7D-849F-93C1DA65272FQ41676299-17ECC0B5-2CE2-4859-8F41-659731F94C4CQ42244470-5E896BF9-89B9-4A1B-B19C-F4CFEDF58605Q42624343-3A3B509D-7FFC-4F63-B3C9-04B4ADEDF878Q45390538-E704274B-89B5-4A8B-A237-DD59F0A5B588Q48143702-D582A1FF-EAD1-4111-B98B-9D18336F7DBDQ48308032-1EFF3E3A-334A-4494-AC8C-F63C603A9837Q48684209-EB7F5153-252F-4455-99CA-BD07267887E7Q50654281-0A546A81-5C7E-472B-A197-6DFDFCB8C4CEQ60636473-6232C76F-0FC7-43E7-AAE5-AB9E6C46C226Q89313124-D80282FB-1959-419D-8820-C64D28328955Q92079833-F79F5A63-F22C-48E3-BDFB-0FD3216D7DB2Q92723941-D352D610-750E-403A-9347-CDFC6B736C02
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mohammad K Arababadi
@ast
Mohammad K Arababadi
@en
Mohammad K Arababadi
@es
Mohammad K Arababadi
@nl
Mohammad K Arababadi
@sl
type
label
Mohammad K Arababadi
@ast
Mohammad K Arababadi
@en
Mohammad K Arababadi
@es
Mohammad K Arababadi
@nl
Mohammad K Arababadi
@sl
altLabel
Arababadi MK
@en
prefLabel
Mohammad K Arababadi
@ast
Mohammad K Arababadi
@en
Mohammad K Arababadi
@es
Mohammad K Arababadi
@nl
Mohammad K Arababadi
@sl
P106
P21
P31
P496
0000-0002-4315-8153